SOD1 and amyotrophic lateral sclerosis: In this study, we analyzed and compared various clinical features of the most frequent (likely) pathogenic variants of SOD1-ALS in the German population, in order to characterize differences with regard to the clinical phenotype, which is highly relevant in the context of planning and evaluating new therapeutic approaches, such as tofersen.